The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 10, 2023
Filed:
Jul. 14, 2020
Applicant:
Sequessome Technology Holdings Limited, Valletta, MT;
Inventors:
Richard Wolf Garraway, Greater London, GB;
William Henry, Greater London, GB;
Assignee:
SEQUESSOME TECHNOLOGY HOLDINGS LIMITED, Valletta, MT;
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/127 (2006.01); A61K 47/24 (2006.01); A61K 47/26 (2006.01); A61K 31/155 (2006.01); A61K 31/165 (2006.01); A61K 31/355 (2006.01); A61K 31/522 (2006.01); A61K 31/60 (2006.01); A61K 31/618 (2006.01); A61Q 19/08 (2006.01); A61K 9/10 (2006.01); A61K 31/7008 (2006.01); A61K 31/737 (2006.01); A61K 8/04 (2006.01); A61Q 19/00 (2006.01); A61Q 19/02 (2006.01); A61K 9/00 (2006.01); A61P 17/10 (2006.01); A61P 17/04 (2006.01); A61K 8/14 (2006.01); A61K 33/30 (2006.01);
U.S. Cl.
CPC ...
A61K 9/1272 (2013.01); A61K 8/04 (2013.01); A61K 8/14 (2013.01); A61K 9/0014 (2013.01); A61K 9/10 (2013.01); A61K 9/127 (2013.01); A61K 31/155 (2013.01); A61K 31/165 (2013.01); A61K 31/355 (2013.01); A61K 31/522 (2013.01); A61K 31/60 (2013.01); A61K 31/618 (2013.01); A61K 31/7008 (2013.01); A61K 31/737 (2013.01); A61K 47/24 (2013.01); A61K 47/26 (2013.01); A61P 17/04 (2018.01); A61P 17/10 (2018.01); A61Q 19/00 (2013.01); A61Q 19/02 (2013.01); A61Q 19/08 (2013.01); A61K 33/30 (2013.01); A61K 2300/00 (2013.01);
Abstract
The present invention relates to compositions comprising a colloidal dispersion and an Agent of Interest ('AOI'), wherein the colloidal dispersion comprises deformable colloidal particles and wherein the AOI is not associated with the deformable colloidal particles. The present invention also provides kits and transdermal drug release devices comprising the compositions of the present invention, and the use of these compositions in medicine, skin care and cosmetics.